Stockreport

https://seekingalpha.com/article/4758654-anavex-looking-at-different-statistical-approaches-before-ema-opinion [Seeking Alpha]

Anavex Life Sciences Corp.  (AVXL) 
NASDAQ:AMEX Investor Relations: anavex.com/share-data
PDF Despite mixed trial results, blarcamesine showed significant cognitive improvements, meeting key endpoints, though it failed in functional assessments. Financially, A [Read more]